Apellis Pharmaceuticals Inc (APLS)
33.18
+0.04
(+0.11%)
USD |
NASDAQ |
Dec 20, 16:00
33.18
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals Total Liabilities (Quarterly): 664.74M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen Inc | 11.95B |
| Biomarin Pharmaceutical Inc | 1.438B |
| Ionis Pharmaceuticals Inc | 2.419B |
| QuidelOrtho Corp | 3.614B |
| Moderna Inc | 3.876B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 901.87M |
| Shareholders Equity (Quarterly) | 237.12M |
| Debt to Equity Ratio | 1.907 |
| Current Ratio | 4.36 |
| Net Debt Paydown Yield | -2.04% |